Drotrecogin Alfa (Activated) Administration: Too Many Subgroups
- 1 October 2003
- journal article
- letter
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 31 (10) , 2564-5
- https://doi.org/10.1097/01.ccm.0000089929.73924.4c
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsisCritical Care Medicine, 2003
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in AdultsJAMA, 1995
- Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against EndotoxinNew England Journal of Medicine, 1991